GSK declines to apologise for vaccine trials in mother and baby homes
Pharma giant’s own documents show it conducted seven trials at homes over almost four decades
The pharmaceutical giant GlaxoSmithKline (GSK) has declined to apologise for conducting what have been found to have been unethical vaccine trials on children in mother and baby homes.
The firm cooperated with the investigation of the Mother and Baby Home Commission, and provided documentation from its archives which showed there were seven such trials between 1934 and 1973. They were carried out by Glaxo Limited and the Wellcome Foundation, which merged into GSK in 2000.
The final report...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Elaine Byrne: We are now paying the price for our lack of urgency on gambling controls
The comments by President Higgins on the proliferation of sports betting ads and the huge damage inflicted on families by gambling deserve our close attention
‘Support progamme needed for the 10,000 children who have a parent in prison’
New report by Irish Penal Reform trust says lack of in-person visits during pandemic has affected children’s mental and physical health
Silence is deafening when it comes to putting right the wrong of the school dress code story
The refusal by a number journalists and public figures to apologise for propagating an unfounded and damaging rumour is deeply disturbing
Timetable to end direct provision is unrealistic, DPER officials warn
Concerns have been expressed by senior civil servants in the Department of Public Expenditure and Reform that the new system will be restricted by constraints in the housing market